 |
인쇄하기
취소
|
Pharmaceutical Industry Raises Doubts on Bio-Equivalent Test
The pharmaceutical industry has issued a strong opinion regarding the bio-equivalent test, saying that its implementation only for the sale of substitutable dispensation without any consideration of the economic factors should be restrained.
The KFDA has been receiving the requisition for the test and as of August 6 the number of items is estimated at 570.
However, some of the applied it...
The KFDA has been receiving the requisition for the test and as of August 6 the number of items is estimated at 570.
However, some of the applied it...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.